74 (PB064) - Molecular characterization of primary and secondary resistance to RET inhibitors in patients with advanced NSCLC and RET fusions.

Authors :: Marinello, A.
Vasseur, D.
Conci, N.
Lindsay, C.
Metro, G.
Ferrara, R.
Eisert, A.
Citarella, F.
Fallet, V.
Audugier-Valette, C.
Cousin, S.
Tabbò, F.
Russo, A.
Calles Blanco, A.
Iranzo Gomez, P.
Tagliamento, M.
Mezquita, L.
Ponce, S.
Besse, B.
Aldea, M.
Source :: European Journal of Cancer. 2022 Supplement 1, Vol. 174, pS26-S26. 1p.
Publication Year :: 2022

Subjects :: *LUNG cancer
*DRUG resistance
*CONFERENCES & conventions
*CANCER patients
*MOLECULAR biology
*PROTEIN-tyrosine kinase inhibitors
*GENE rearrangement

Full Text Access

Tools